India Has Removed Import & Export Licence Requirements for Biological Samples

26 Aug, 2016 by  Amine Benmoussa

The Indian government has allowed for easier import and export of various biological samples by removing the mandatory requirement of an export and import license for these samples, announced Mr Anup Wadhawan, Director General of Foreign Trade (DGFT), on August 4, 2016. The new ruling will save CROs, biotech companies and research centers significantly shorter import and export approval times.


Prior to this, companies in the contract research sector were forced to go through a licensing process that took almost 4-5 months to get or send out every human biological sample for research or commercial purposes. Every sample handling had to be authorized by the Indian Council of Medical Research (ICMR), which only meets once in three months, causing long delays.


With the new notification, an organization is only required to provide a self-certification to the customs authority that they are and will follow all the applicable rules, regulations and procedures for safe transfer and disposal of the biological samples.


This is very good news for the companies shipping clinical samples in and out of India.

About Amine Benmoussa
EMEA Trade Compliance Manager

With almost 15 years experience in the industry, Amine has built extensive knowledge across various regions and provides specific and customized regulatory information for the transportation of Clinical Trial Supplies (IMP... Read more.

Recent Blog Posts: